Study guide
6.4 Indications & Timing for Induction of Labor
AMCB Certified Nurse-Midwife CNM
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care
1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral
2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts
2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy
3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy
3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy
4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss
4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care
5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance
5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion
6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation
6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy
7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair
7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture
8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation
8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications
9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage
9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation
10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health
10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis
11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination
11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes
12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days
12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days
13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization
13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening
14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation
14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral
15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders
15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome
16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause
16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis
17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions
17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking
18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity
18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care
6.4 Indications & Timing for Induction of Labor
Key Takeaways Explain This Topic AI
Routine induction is recommended between 41 0/7 and 42 0/7 weeks and should not be delayed beyond 42 0/7 weeks.
The ARRIVE trial randomized 6,106 low-risk nulliparas and found elective induction at 39 weeks reduced cesarean birth from 22.2 to 18.6 percent and hypertensive disorders from 14.1 to 9.1 percent.
Elective induction before 39 0/7 weeks remains contraindicated because of neonatal respiratory morbidity.
In fetal growth restriction, absent end-diastolic umbilical artery flow warrants delivery at 33 to 34 weeks and reversed end-diastolic flow warrants delivery at 30 to 32 weeks.
Absolute contraindications to induction include prior classical or T-shaped hysterotomy, complete placenta previa or vasa previa, active genital herpes lesions, transverse lie, and cord prolapse.
Last updated: September 2026
Quick Summary: Induction of labor is indicated when the risks of continuing the pregnancy outweigh the risks of birth, and each condition carries its own gestational-age target. This section covers the medically indicated conditions and their timing, the ARRIVE trial evidence behind elective induction at 39 weeks, and the absolute contraindications. Cervical preparation, oxytocin, and amniotomy follow in the next two sections.
Indications & Timing for Induction of Labor
Induction of labor is indicated when the maternal or fetal risks of continuing the pregnancy outweigh the potential risks of labor induction and delivery.
Medically Indicated Labor Induction
Common evidence-based indications and their recommended gestational timing established by the American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM) include:
Postterm & Late-Term Pregnancy: Late-term pregnancy spans 41 0/7 to 41 6/7 weeks; postterm pregnancy is defined as ≥ 42 0/7 weeks. Perinatal mortality, stillbirth, oligohydramnios, meconium aspiration syndrome, and macrosomia rise steadily past 41 weeks. Routine labor induction is strongly recommended between 41 0/7 and 42 0/7 weeks , and should not be delayed beyond 42 0/7 weeks.
Preeclampsia & Gestational Hypertension: For gestational hypertension or preeclampsia without severe features, induction is indicated at 37 0/7 weeks . In the presence of severe features (e.g., persistent severe blood pressure ≥ 160/110 mmHg, platelets < 100,000/mcL, elevated transaminases, progressive renal insufficiency, pulmonary edema, or intractable neurological symptoms), delivery is indicated at 34 0/7 weeks , or immediately upon maternal stabilization at any gestational age.
Prelabor Rupture of Membranes (PROM) at Term: At ≥ 37 0/7 weeks, labor induction with oxytocin significantly reduces the latency period and maternal infectious morbidity (chorioamnionitis, endometritis) compared to expectant management, without increasing the cesarean delivery rate.
Oligohydramnios: An amniotic fluid index (AFI) < 5 cm or maximum vertical pocket (MVP) < 2 cm at term (≥ 37 0/7 weeks) warrants labor induction due to increased risks of cord compression, placental senescence, and fetal compromise.
Gestational Diabetes Mellitus (GDM): In well-controlled, diet-managed A1GDM, expectant management up to 40 6/7 weeks is appropriate. For medically managed A2GDM on insulin or oral hypoglycemics with good glycemic control, induction is recommended between 39 0/7 and 39 6/7 weeks . Poorly controlled GDM may require earlier delivery (37 0/7 to 38 6/7 weeks).
Fetal Growth Restriction (FGR): Estimated fetal weight (EFW) or abdominal circumference < 10th percentile. If accompanied by abnormal umbilical artery Doppler velocimetry (decreased end-diastolic velocity), delivery is typically indicated at 37 0/7 weeks; absent end-diastolic flow (AEDF) warrants delivery at 33–34 weeks; reversed end-diastolic flow (REDF) necessitates immediate delivery (often via cesarean) at 30–32 weeks.
Other Indications: Chorioamnionitis (immediate induction/delivery regardless of gestational age), placental abruption (hemodynamically stable without severe fetal compromise), and medically stable chronic medical conditions (renal disease, systemic lupus erythematosus).
Elective Induction of Labor at 39 Weeks: The ARRIVE Trial
Historically, elective induction in nulliparous women was thought to double the risk of cesarean delivery compared to spontaneous labor. However, this observational comparison suffered from an inherent methodological flaw: comparing women induced at a specific gestational age to women delivering spontaneously at that same age, rather than to women managed expectantly (many of whom later required medically indicated inductions or cesarean sections post-dates).
The ARRIVE Trial ( A Randomized Trial of Induction Versus Expectant Management , Grobman et al., NEJM 2018) addressed this question by randomizing 6,106 low-risk nulliparous women between 39 0/7 and 39 4/7 weeks to either elective induction of labor or expectant management:
- Outcome Parameter Elective Induction at 39 Weeks Expectant Management Group Relative Risk / Significance
- Primary Cesarean Delivery Rate 18.6% 22.2% RR 0.84 (95% CI 0.76–0.93) ; Statistically significant reduction
- Gestational Hypertensive Disorders 9.1% 14.1% RR 0.64 (95% CI 0.56–0.74) ; Statistically significant reduction
- Adverse Perinatal Composite 4.3% 5.4% RR 0.80 (95% CI 0.64–1.00); No significant difference
- Neonatal Respiratory Support 3.0% 4.2% Statistically significant reduction
Maternal Pain & Labor Agency Reported lower perceived labor pain and higher sense of control Standard labor experience Enhanced maternal satisfaction scores
Midwifery Practice Note: ACOG and ACNM affirm that elective induction of labor at 39 0/7 to 39 4/7 weeks in low-risk nulliparous women is a reasonable, evidence-based option that must be offered through shared decision-making. Elective induction prior to 39 0/7 weeks remains strictly contraindicated due to elevated neonatal respiratory morbidity.
Absolute Contraindications to Labor Induction
Prior classical, T-shaped, or inverted-T hysterotomy incision, or prior extensive transfundal myomectomy entering the uterine cavity.
Complete placenta previa or vasa previa.
Active genital herpes simplex virus (HSV) infection with visible lesions or prodromal symptoms.
Transverse fetal lie or unstable malpresentation.
Umbilical cord prolapse or funic presentation.
Invasive cervical carcinoma.
Severe cephalopelvic disproportion.